<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(1)</volume><submitter>Rahimov F</submitter><pubmed_abstract>Interleukin-1β (IL-1β) is dysregulated in chronic inflammatory diseases, yet the genetic factors influencing IL-1β production remain largely unknown. Myeloid-derived cells are the primary producers of IL-1β, which prompted a genome-wide CRISPR knockout screen in the human myeloid-derived U937 cells treated with lipopolysaccharide (LPS) to mimic inflammatory conditions and sorted for high and low intracellular IL-1β levels. A total of 295 genes are identified as regulators of IL-1β production, with 57 overlapping loci associated with inflammatory diseases, including the TNRC18 gene locus associated with multiple diseases in the Finnish population. U937 cells engineered with the Finnish-enriched rs748670681 risk allele demonstrate decreased expression of TNRC18 and an adjacent gene WIPI2, re</pubmed_abstract><journal>Nature communications</journal><pagination>10346</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12644769</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A genome-wide CRISPR screen identifies the TNRC18 gene locus as a regulator of inflammatory signaling.</pubmed_title><pmcid>PMC12644769</pmcid><pubmed_authors>Shi M</pubmed_authors><pubmed_authors>den Hollander AI</pubmed_authors><pubmed_authors>Espinoza CA</pubmed_authors><pubmed_authors>Waring JF</pubmed_authors><pubmed_authors>Rahimov F</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Mahi NA</pubmed_authors><pubmed_authors>Schmidt M</pubmed_authors><pubmed_authors>Modi A</pubmed_authors><pubmed_authors>Avram V</pubmed_authors><pubmed_authors>Anton T</pubmed_authors><pubmed_authors>Verduzco D</pubmed_authors><pubmed_authors>Singh S</pubmed_authors><pubmed_authors>Katlinski KV</pubmed_authors><pubmed_authors>Nyamugenda E</pubmed_authors><pubmed_authors>Macoritto M</pubmed_authors><pubmed_authors>Tam J</pubmed_authors><pubmed_authors>Lu C</pubmed_authors><pubmed_authors>Chung N</pubmed_authors><pubmed_authors>Biswas A</pubmed_authors><pubmed_authors>Stender JD</pubmed_authors><pubmed_authors>Ghosh S</pubmed_authors><pubmed_authors>Keller A</pubmed_authors><pubmed_authors>Flister MJ</pubmed_authors><pubmed_authors>Petiwala S</pubmed_authors></additional><is_claimable>false</is_claimable><name>A genome-wide CRISPR screen identifies the TNRC18 gene locus as a regulator of inflammatory signaling.</name><description>Interleukin-1β (IL-1β) is dysregulated in chronic inflammatory diseases, yet the genetic factors influencing IL-1β production remain largely unknown. Myeloid-derived cells are the primary producers of IL-1β, which prompted a genome-wide CRISPR knockout screen in the human myeloid-derived U937 cells treated with lipopolysaccharide (LPS) to mimic inflammatory conditions and sorted for high and low intracellular IL-1β levels. A total of 295 genes are identified as regulators of IL-1β production, with 57 overlapping loci associated with inflammatory diseases, including the TNRC18 gene locus associated with multiple diseases in the Finnish population. U937 cells engineered with the Finnish-enriched rs748670681 risk allele demonstrate decreased expression of TNRC18 and an adjacent gene WIPI2, re</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T18:52:20.829Z</modification><creation>2026-05-20T03:14:14.058Z</creation></dates><accession>S-EPMC12644769</accession><cross_references><pubmed>41285767</pubmed><doi>10.1038/s41467-025-65277-y</doi></cross_references></HashMap>